TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR

DESLORATADINE Histamine H1 Receptor Antagonists
Infectious Disease Approved 2011-04-26
1
Indication
--
Phase 3 Trials
14
Years on Market

Details

Status
Prescription
First Approved
2011-04-26
Routes
ORAL
Dosage Forms
TABLET, EXTENDED RELEASE

Companies

Active Ingredient: DESLORATADINE , PSEUDOEPHEDRINE SULFATE

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR Approval History

Loading approval history...

What DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR Treats

3 indications

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR is approved for 3 conditions since its original approval in 2011. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Seasonal Allergic Rhinitis
  • Perennial Allergic Rhinitis
  • Chronic Idiopathic Urticaria
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR FDA Label Details

Pro

Indications & Usage

Desloratadine Tablets are a histamine-1 (H1) receptor antagonist indicated for: • Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. • Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 12 years of age and older. • Chronic Idiopathic Urticaria: symptomatic relief of pruritus, reduction in the number of hives, and size of hives in patients 12 years of age and older. 1.1 Seasonal Allergic Rhinitis Desloratadine Tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis ...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.